文献速递脑血管病认知障碍与痴呆

强化与标准血压控制对脑血流量的关联:SPRINT MIND 随机临床试验的二次分析

Association of Intensive vs Standard Blood Pressure Control With Cerebral Blood Flow: Secondary Analysis of the SPRINT MIND Randomized Clinical Trial.
PubMed 文献 · JAMA Neurol · 2022-01-01

该研究为 SPRINT 子研究,纳入 547 名有基线脑血流测量的高血压患者,随机接受强化降压(收缩压目标<120 mm Hg)或标准降压(<140 mm Hg)。中位随访 4.0 年后,强化组全脑脑血流量平均增加 1.46 mL/100 g/min,标准组无平均增加,组间差异为 2.30 mL/100 g/min(95% CI 0.30-4.30,P=0.02)。结论认为强化降压与脑灌注增加而非降低相关。

要点

  • 强化降压组全脑脑血流量平均增加 1.46 mL/100 g/min,标准组无平均增加。
  • 组间脑血流量变化差异为 2.30 mL/100 g/min(95% CI 0.30-4.30,P=0.02)。
  • 有心血管疾病史者强化治疗与脑血流量增加关联更明显(交互作用 P=0.05)。

核心结论

  • 强化与标准降压治疗相比,与脑灌注增加而非降低相关,在有心血管疾病史的参与者中最为明显。

研究设计与样本

  • SPRINT 随机临床试验的子研究,比较两种降压策略,采用纵向脑磁共振成像包括动脉自旋标记灌注成像量化脑血流量。
  • 从美国 6 个中心筛查 1267 名 50 岁及以上、有高血压和心血管风险增加但无糖尿病或痴呆的成人。
  • 随机化始于 2010 年 11 月,最终随访 MRI 于 2016 年 7 月完成,分析于 2020 年 9 月至 2021 年 12 月进行。
  • 547 名参与者有基线脑血流量测量,平均(SD)年龄 67.5(8.1)岁,219 名(40.0%)为女性;315 名在随机化后中位(IQR)4.0(3.7-4.1)年完成随访 MRI。

主要发现

  • 强化治疗组全脑脑血流量平均值从 38.90 增至 40.36(差值 1.46 [95% CI 0.08-2.83] mL/100 g/min),标准治疗组无平均增加(37.96 至 37.12;差值 -0.84 [95% CI -2.30 至 0.61] mL/100 g/min)。
  • 组间差异为 2.30(95% CI 0.30-4.30;P=0.02)mL/100 g/min。
  • 灰质、白质和脑室周围白质脑血流量显示相似变化。
  • 按年龄、性别、种族、慢性肾脏病、收缩压、体位性低血压和衰弱定义的亚组中,强化与标准治疗和脑血流量的关联总体相似,例外是有心血管疾病史者强化治疗与脑血流量平均增加更大相关(交互作用 P=0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Antihypertensive treatments benefit cerebrovascular health and cognitive function in patients with hypertension, but it is uncertain whether an intensive blood pressure target leads to potentially harmful cerebral hypoperfusion. OBJECTIVE: To investigate the association of intensive systolic blood pressure (SBP) control vs standard control with whole-brain cerebral blood flow (CBF). DESIGN, SETTING, AND PARTICIPANTS: This substudy of the Systolic Blood Pressure Intervention Trial (SPRINT) randomized clinical trial compared the efficacy of 2 different blood pressure-lowering strategies with longitudinal brain magnetic resonance imaging (MRI) including arterial spin labeled perfusion imaging to quantify CBF. A total of 1267 adults 50 years or older with hypertension and increased cardiovascular risk but free of diabetes or dementia were screened for the SPRINT substudy from 6 sites in the US. Randomization began in November 2010 with final follow-up MRI in July 2016. Analyses were performed from September 2020 through December 2021. INTERVENTIONS: Study participants with baseline CBF measures were randomized to an intensive SBP target less than 120 mm Hg or standard SBP target less than 140 mm Hg. MAIN OUTCOMES AND MEASURES: The primary outcome was change in whole-brain CBF from baseline. Secondary outcomes were change in gray matter, white matter, and periventricular white matter CBF. RESULTS: Among 547 participants with CBF measured at baseline, the mean (SD) age was 67.5 (8.1) years and 219 (40.0%) were women; 315 completed follow-up MRI at a median (IQR) of 4.0 (3.7-4.1) years after randomization. Mean whole-brain CBF increased from 38.90 to 40.36 (difference, 1.46 [95% CI, 0.08-2.83]) mL/100 g/min in the intensive treatment group, with no mean increase in the standard treatment group (37.96 to 37.12; difference, -0.84 [95% CI, -2.30 to 0.61] mL/100 g/min; between-group difference, 2.30 [95% CI, 0.30-4.30; P = .02]). Gray, white, and periventricular white matter CBF showed similar changes. The association of intensive vs standard treatment with CBF was generally similar across subgroups defined by age, sex, race, chronic kidney disease, SBP, orthostatic hypotension, and frailty, with the exception of an indication of larger mean increases in CBF associated with intensive treatment among participants with a history of cardiovascular disease (interaction P = .05). CONCLUSIONS AND RELEVANCE: Intensive vs standard antihypertensive treatment was associated with increased, rather than decreased, cerebral perfusion, most notably in participants with a history of cardiovascular disease. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01206062.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Dolui S, Detre JA, Gaussoin SA, et al. Association of Intensive vs Standard Blood Pressure Control With Cerebral Blood Flow: Secondary Analysis of the SPRINT MIND Randomized Clinical Trial. JAMA Neurol. 2022. PMID: 35254390. doi:10.1001/jamaneurol.2022.0074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。